Skip to contentSkip to footer
Catalyst Health Ventures
Catalyst Health Ventures
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
1 800 458 56 97
Investor Portal
Catalyst Health Ventures
Investor Portal
Close
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
linkedin
Get in Touch
info@chv.vc
Our Address
129 South Street, 4th Floor,
Boston, MA 02111
Investor Portal
Conformal

Novel Conformable Foam-Based Implant for Left Atrial Appendage Closure: Conformable EFS Experience

October 15, 2020

To view Conformal‘s presentation at TCT 2020 by William Gray, MD, please click here

Post navigation

Previous
Instylla Announces Completion of Series B Financing
October 14, 2020
Next
Conformal Medical’s CLAAS® Stroke Prevention Technology Announces Promising Clinical Results at 2020 TCT Conference
October 16, 2020

You May Also Like

JSCAI Publishes Peer-Reviewed Article Highlighting Effective Performance of Conformal Medical’s Left Atrial Appendage (CLAAS®) Device
January 8, 2023
W. L. Gore & Associates to Acquire Conformal Medical, Expanding its Presence in Endovascular Treatments
January 5, 2026
Catalyst Health Ventures
Catalyst Health Ventures (CHV) is a venture capital firm investing in transformative medical technologies addressing global unmet needs.
Office

129 South Street, 4th Floor,
Boston, MA 02111

info@chv.vc

Links
  • Home
  • About
  • Portfolio
  • Meet Our Team
  • News
  • Connect
Get In Touch
  • LinkedIn

© 2026 Catalyst Health Ventures. All Rights Reserved | Site By ConvyLab